🔴 Indaptus Therapeutics is trading 7.3% down today as pre-market gains reverse

Indaptus Therapeutics is trading at $2.42 (-7.28%) as the stock reverses its earlier pre-market rebound.

• The decline follows a selloff on Friday, with the stock failing to maintain momentum despite a positive pre-market session.
• There is no fresh company-specific news to explain the move, suggesting the drop is idiosyncratic rather than market-driven.
• The downward trend occurs despite broader markets showing risk-on sentiment this morning.